about
Cystatin C: a candidate biomarker for amyotrophic lateral sclerosisApplying proteomics to the diagnosis and treatment of ALS and related diseases.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?The application of biomarkers in clinical trials for motor neuron diseaseGenetic biomarkers for ALS disease in transgenic SOD1(G93A) miceDiscovery and verification of amyotrophic lateral sclerosis biomarkers by proteomicsMechanisms, models and biomarkers in amyotrophic lateral sclerosisCombination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis.Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.Spinal cord markers in ALS: diagnostic and biomarker considerations.Circulating miRNAs as biomarkers for neurodegenerative disorders.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Further development of biomarkers in amyotrophic lateral sclerosis.Biomarkers in Neurodegenerative Diseases.Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.Circulating microRNAs in Neurodegenerative Diseases.Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS
P2860
Q28476466-9349150D-3B78-4929-A2E1-5514AA5B72A3Q33719446-05F8DB63-6AA4-4AFC-865C-561D84F38ED0Q33767845-EEC41ED7-A6D6-4B58-BFFC-55A07B57A025Q33961751-47D786D7-2600-45B2-86A4-C02A6099B41CQ34193281-824EFCD0-7DB2-4BD3-98FA-D1B4FC2CB9B7Q34285662-4F0350AC-2382-4E5C-BEDD-0E22B69FE069Q34344992-14A82D2C-19D0-4A1C-9F41-2F5F8B3E95F4Q34792280-98D55824-E436-48D4-B659-C79EDCA5AB0DQ37487611-2269DA05-2D32-4B25-96C7-D4C99A6820FCQ37944427-21462024-0E96-4BB1-BCE2-47561CCDA1BEQ37972903-F1F6640C-F485-485B-BFDA-3B01C253B7B8Q37983648-58B30809-5E0C-4DF5-A6BC-CF98F7DA45DBQ38214427-CF7F13E4-FE7C-4202-A61B-93922E4F7477Q38847200-CDD64171-5CFC-46A9-B8C8-E7D450B3F6A2Q38856405-3BEA4C36-39C2-4786-9D00-64F48587819FQ39413097-BC9B1C61-B24C-4630-8B7E-4D7C1342DF2CQ42369773-E805654E-E1F9-496F-92F8-663712850B97Q48713195-28D3249F-C38F-4E10-818F-060FD435C8B5Q58612356-8980B83C-0F3A-4104-9B7E-CC1908E62C85
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein biomarkers for amyotrophic lateral sclerosis.
@en
Protein biomarkers for amyotrophic lateral sclerosis.
@nl
type
label
Protein biomarkers for amyotrophic lateral sclerosis.
@en
Protein biomarkers for amyotrophic lateral sclerosis.
@nl
prefLabel
Protein biomarkers for amyotrophic lateral sclerosis.
@en
Protein biomarkers for amyotrophic lateral sclerosis.
@nl
P2860
P356
P1476
Protein biomarkers for amyotrophic lateral sclerosis.
@en
P2093
Henrik Ryberg
Robert Bowser
P2860
P304
P356
10.1586/14789450.5.2.249
P577
2008-04-01T00:00:00Z